Monte Rosa Therapeutics, Inc.

GLUE · NASDAQ
Analyze with AI
$15.54−$0.29 (−1.83%)
At close:Dec 19, 2025, 9:00 PM UTC
$15.41−$0.13 (−0.84%)
After hours:Dec 20, 2025, 12:03 AM UTC
P/E TTM61.13
P/B TTM5.21
P/S TTM5.57
Dividend Yield0%
EPS$0.32
Beta1.601
Valuation
PEG Ratio-5.35
FCF Yield14.33%
EV / EBITDA43.14
Quality
ROIC2.02%
Gross Margin98.85%
Cash Conv. Ratio7.12
Growth
Revenue 3Y CAGR
FCF Growth160.48%
Safety
Net Debt / EBITDA-8.60
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-2,517.84

Monte Rosa Therapeutics, Inc. (GLUE) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Monte Rosa Therapeutics, Inc. (GLUE) stock price today?

As of Dec 19, 2025, 9:00 PM UTC, Monte Rosa Therapeutics, Inc. (GLUE) stock is trading at $15.54. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date GLUE stock quotes for informed trading decisions.

What is Monte Rosa Therapeutics, Inc.'s market capitalization?

Monte Rosa Therapeutics, Inc. (GLUE) has a market capitalization of approximately $1.0B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Monte Rosa Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the GLUE stock price changes.

What is the 52-week range for Monte Rosa Therapeutics, Inc. stock?

Monte Rosa Therapeutics, Inc. (GLUE) stock has traded in a 52-week range of $3.50 — $19.17. The 52-week range shows the highest and lowest prices at which GLUE traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Monte Rosa Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Monte Rosa Therapeutics, Inc. stock have?

Monte Rosa Therapeutics, Inc. (GLUE) stock recently traded approximately 4.7M shares. Trading volume indicates market liquidity and investor interest in GLUE. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Monte Rosa Therapeutics, Inc. stock.

Does Monte Rosa Therapeutics, Inc. pay dividends to shareholders?

Yes, Monte Rosa Therapeutics, Inc. (GLUE) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Monte Rosa Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Monte Rosa Therapeutics, Inc.'s intraday price range?

Today, Monte Rosa Therapeutics, Inc. (GLUE) stock has traded in a range of $15.33 — $16.25. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring GLUE's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Monte Rosa Therapeutics, Inc. stock data?

AlphaPilot sources real-time GLUE stock quotes, fundamental financial data, and historical price charts for Monte Rosa Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Monte Rosa Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of GLUE stock performance.